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abstract: Objectives: Haematopoietic stem cell transplantation (HSCT) in Oman started in 1994 at Sultan Qaboos 
University Hospital (SQUH), Muscat, Oman. Previous studies have suggested that longer driving time to the trans- 
plant centre (DTC) independently correlates with worse overall survival (OS). Therefore, this study aimed to examine 
the impact of DTC on OS and acute graft-versus-host disease (aGvHD). Methods: This retrospective study included 
all patients who underwent HSCT between February 2006 and December 2016 at SQUH. The DTC was determined 
using Google Maps (Google LLC., Mountain View, California, USA). The probability of OS was estimated using a 
Kaplan-Meier estimator and the impact of DTC on OS was compared using a Cox model. Results: A total of 170 
patients were included in this study of which 52% were male and 28% were from the Al Batinah region. The mean age 
was 14.2 ± 12.2 years. The mean haemoglobin, platelet and white blood cell counts before the HSCT were 10.3 ± 1.7 g/dL, 
207 ± 131 × 109/L and 5.1 ± 5.9 × 109/L, respectively. The median DTC for those with aGvHD was 84 minutes, which 
is similar to patients without aGvHD (P = 0.918). The hazard ratio for DTC as a predictor of OS was 1.0 (P = 0.901). 
Conclusion: In this single centre study, DTC did not impact aGvHD or OS in patients post-HSCT. The study was 
limited by its retrospective design and the small sample size. It is recommended that these results be confirmed in a 
prospective study.
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امللخ�ص: الهدف: بداأت زراعة اخلاليا اجلذعية املكونة للدم يف عمان عام 1994 يف م�ست�سفى جامعة ال�سلطان قابو�ض، م�سقط، عمان. بينت 
الدرا�سات ال�سابقة اأن زمن الو�سول اإىل مركز زراعة اخلاليا اجلذعية ترتبط ب�سكل �سلبي مع البقاء علي احلياة ب�سكل عام. لذلك، خططنا لدرا�سة 
تاأثري زمن الو�سول اإىل مركز زراعة اخلاليا اجلذعية على مدى بقاء املري�ض على قيد احلياة وداء الطعم حيال الثوي احلاد. الطريقة: �سملت هذه 
الدرا�سة ال�ستعادية املر�سى الذين خ�سعوا لزراعة اخلاليا اجلذعية من فرباير 2006 اإىل دي�سمرب 2016 يف م�ست�سفى جامعة ال�سلطان قابو�ض. 
مت حتديد زمن الو�سول اإىل مركز زراعة اخلاليا اجلذعية باإ�ستخدام خرائط جوجل )جوجل، ماوننت فيو، كاليفورنيا، اأمريكا(. مت تقدير احتمال 
البقاء علي احلياة ب�سكل عام با�ستخدام مقّدر كابالن ماير ومتت مقارنة تاأثري زمن الو�سول اإىل مركز زراعة اخلاليا اجلذعية على مدى البقاء 
على قيد احلياة ب�سكل عام با�ستخدام منوذج كوك�ض. النتائج: �سملت هذه الدرا�سة ما جمموعه 170 مري�سا، %52 منهم ذكور و %28 من منطقة 
الباطنة. كان متو�سط العمر 14.2 ± 12.2 �سنة. كانت معدلت الهيموجلوبني وال�سفائح الدموية وتعداد خاليا الدم البي�ساء قبل الزراعة هي 
10.3 ± 1.7 جم/دي�سيلرت، 207 ± 131 × 109/لرت و 5.1 ± 5.9 × 109/لرت، على التوايل. كان متو�سط زمن الو�سول اإىل املركز بالن�سبة لأولئك الذين 
لديهم داء الطعم حيال الثوي احلاد 84 دقيقة وهو م�سابه للمر�سى دون الداء )P = 0.918(. كانت ن�سبة اخلطر لـزمن الو�سول كموؤ�رس للبقاء على 
احلياة ب�سكل عام هي 1 والتي مل تكن ذات دللة اإح�سائية )P = 0.901(. اخلال�صة: يف درا�سة هذا املركز الواحد، مل يوؤثر زمن الو�سول اإىل مركز 
زراعة اخلاليا اجلذعية على معدل داء الطعم حيال الثوي احلاد وعلى مدى بقاء احلياة يف املر�سى الذين خ�سعوا لزراعة اخلاليا اجلذعية. كانت 
الدرا�سة حمدودة ب�سبب الت�سميم ال�ستعادي وحجم العينة ال�سغري.نو�سي على تاأكيد هذه النتائج يف درا�سة ا�ستباقية.
الكلمات املفتاحية: زراعة اخلاليا اجلذعية املكونة للدم؛ داء الطعم حيال الثوي؛ حتليل البقاء على احلياة؛ ال�سفر؛ عمان.
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Advances in Knowledge
- This study found that home-to-transplant centre distance had no impact on the survival in patients who receive haematopoietic stem 
cell transplantation or on their risk of acute graft-versus-host disease.
Application to patient care 
- Home-to-transplant centre distance should not impact the decision to proceed with haematopoietic stem cell transplantation (HSCT). 
- Physicians should ensure adequate follow-up for patients post-HSCT regardless of their home-to-transplant centre distance.
Haematopoietic stem cell transplant- ation (HSCT) includes peripheral blood stem cell, umbilical cord stem cell and bone marrow 
transplantations. HSCT is used as a treatment modality 
to replace congenital or acquired life-threating abnormal 
bone marrow with normal haematopoietic stem cells 
to allow haematopoietic reconstitution after chemotherapy 
or chemoradiotherapy.1 A number of complications are 
associated with HSCT, including infections, haemorrhage, 
graft failure, secondary malignancies and chronic and 
acute graft-versus-host disease (aGvHD).2
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Home-to-transplant centre distance, estimated as 
driving time to the transplant centre (DTC), has been 
shown to affect a number of transplant outcomes, albeit 
not consistently. Abou-Nassar et al. found that overall 
survival (OS) after HSCT was 76% for patients who 
spent ≤40 minutes driving time and 65% for patients with 
≥160 minutes driving time.3 Contrary to Abou-Nassar 
et al.’s study, Graupner et al. found no impact of DTC 
on post-transplant hospital length of stay, hospital re- 
admission in the first 100 days and OS at day 100 and 
at one year.4
This study hypothesised that frequent early post-
transplant follow-up of patients living far from the trans- 
plant centre may be difficult to adhere to and result in 
patients not attending as advised. This may impact early 
complications such as aGvHD and treatment related 
mortality. The impact of travelling distance has not been 
investigated on the outcomes of HSCT in Oman or in 
the region. Sultan Qaboos University Hospital (SQUH), 
Muscat, Oman is a tertiary care national institute in the 
capital city with over 600 beds and serves as the only 
allogeneic HSCT centre in Oman, treating patients from 
the entire country. Patients have to travel to the transplant 
centre for their follow-up, which could be up to twice 
per week early in the post-transplant period. This study 
aimed to determine the impact of DTC on OS and the 
probability of developing aGvHD for patients under- 
going HSCT at SQUH.
Methods
This retrospective study was conducted between February 
2006 and December 2016 and included all patients who 
received HSCT at the transplant centre of SQUH, regard- 
less of indication. In addition, patients who had received 
HSCT outside the country and had arrived in Oman before 
day 100 of the HSCT date were included. Patients with 
missing data on OS or on aGvHD development were 
excluded. Furthermore, patients who received autologous 
HSCT as the follow-up in the early post-transplant 
period were also excluded as this is different than allo- 
geneic HSCT and there is no risk of developing aGvHD. 
The decision of the preparative regimen was made using 
a consensus decision during a bone marrow transplant-
ation board discussion.
Driving distance and time from the primary resid- 
ence of patients to SQUH was determined using Google 
Maps, Version 3.32 (Google LLC., Mountain View, Calif- 
ornia, U.S.A) and was considered a continuous variable 
in the analysis of this study. Given that the DTC may 
change during the day as estimated by Google Maps 
(Google LLC.) due to differing traffic conditions, this 
variable was estimated during the same time of the day 
and only during working days. Clinical and laboratory 
information were obtained from the patient’s electronic 
health records. 
Continuous variables were described using means 
with standard deviations or medians if the variable was 
not normally distributed. Categorical variables were 
described using frequencies and percentages. The prob- 
ability of OS was projected using the Kaplan-Meier estim- 
ator and the impact of DTC on OS was compared using 
a Cox proportional hazard model. DTC was compared 
between patients with and without aGvHD using a t-test. 
Collected data were analysed using Statistical Package for 
Social Science (SPSS), Version 22 (IBM Corp., Armonk, 
New York, USA). An alpha threshold of 0.05 was used 
to determine statistical significance. 
This study was reviewed and approved by the 
Ethics Committee of the College of Medicine and Health 
Sciences at SQUH (MRCE #1598). 
Results
A total of 170 patients were included in this study, with 
slightly more males than females (52% versus 48%). 
Most patients were from the Al Batinah region (28%) 
[Figure 1]. The mean age, haemoglobin, platelet, white 
blood cell count and absolute neutrophil counts at the 
time of transplant were 14.2 ± 12.2 years, 10.3 ± 1.7 g/dL, 
207 ± 131 × 109/L, 5.1 ± 5.9 × 109/L and 2.5 ± 4.8 × 109/L, 
respectively. Patients were transplanted for various indic- 
ations, including acute leukaemia (n = 41), sickle cell 
disease (n = 28), immunodeficiency (n = 22), thalassaemia 
major (n = 12), lymphoma (n = 8), Fanconi’s anaemia 
(n = 7), severe aplastic anaemia (n = 7), chronic myeloid 
leukaemia (n = 4), paroxysmal nocturnal haemoglobinuria 
(n = 3) and various other indications (n = 38). Transplanted 
stem cells were collected from peripheral stem cells for 
120 patients, from bone marrow for 49 patients and from 
both sources for one patient. All patients received matched 
sibling donors. The prophylaxis for aGvHD was either 
 
Figure 1: Distribution of all patients who received haemato- 
poietic stem cell transplantation at the transplant centre of 
Sultan Qaboos University Hospital, Muscat, Oman according 
to the governorate of residence (N = 170).
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cyclosporine or tacrolimus with a short course of metho- 
trexate for all patients. The median driving distance and 
time were 137 km (range: 6.6–997 km) and 84 minutes 
(range: 11–594 minutes).
Figure 2 shows the boxplot distribution of the DTC 
variable in patients with and without aGvHD. Both distrib- 
utions were similar and had a similar median DTC of 
84 minutes with no statistically significant difference 
(P = 0.918). The mean of the DTC was 106 ± 115 minutes 
in patients without aGvHD and 110 ± 137 minutes in 
patients with aGvHD. The probability of OS for all patients 
at 2 and 5 years after HSCT were 89% and 80%, respect- 
ively. Figure 3 illustrates the probability of OS over time 
in patients lower and higher than the median DTC. The 
impact of DTC on OS as assessed by a Cox proportional 
hazard model revealed a hazard ratio of 1.0 with no stat- 
istically significant impact of DTC on the OS (P = 0.901). 
Given the lack of impact in the univariable analysis of 
DTC on both OS and aGvHD, multivariable analyses 
were not performed in the current study.
Discussion 
A number of studies have addressed disparities in cancer 
survival rates based on geographic proximity to the treat- 
ment center.5,6 However, studies which examine the 
impact of home-to-transplant centre distances on the 
OS and risk of developing aGvHD in patients under- 
going HSCT are scarce.3–6 To the best of the authors’ 
knowledge, this is the first study to address this issue 
in Oman or in the region. 
A retrospective cohort study from Nebraska assessed 
whether the primary area of residence was an indep- 
endent risk factor for OS in patients undergoing auto- 
logous and allogeneic HSCT.4 A significant impact was 
found among patients undergoing autologous HSCT, but 
not with allogeneic HSCT. Those from rural areas were 
found to have a significantly lower survival rate (73%) 
compared to those from urban areas (78%; P = 0.04).4 
However, the hazard ratio observed in this study provides 
evidence that patients from rural areas undergoing allo- 
geneic HSCT are not at a greater risk of mortality than 
patients from urban areas. Associations found in other 
studies may be related to the type of health insurance 
coverage in urban versus rural areas. In Oman, all Omanis 
have governmental health insurance, which covers HSCT. 
This may have led to the lack of impact of DTC on 
OS in this study as all patients, regardless of their area 
of residence, had equal access to healthcare. The differ- 
ences in the transport system of Nebraska and Oman 
may have led to some of the differing outcomes observed 
between the two studies.4 Given the previous literature, 
DTC was not expected to have an impact on autol- 
ogous HSCT and the expected low mortality from this 
kind of transplantation lead to its exclusion from the 
current study.4 
The gender ratio in the current study was approx- 
imately equal, which is representative of the ratio in the 
general Omani population.7 Most of the patients were 
from the Al Batinah and Muscat regions, which reflects 
the population distribution in Oman. No significant rela- 
tionship was found between the area of residence and 
OS as assessed by the Cox regression analysis. Additio- 
nally, Omani patients receiving HSCT are generally 
younger than those reported in studies from Europe and 
North America.8 Therefore, the association between 
DTC and OS may not be as strong in younger patients 
when compared to older patients. Finally, many of the 
patients who received HSCT in the present study were 
transplanted for benign conditions that generally have 
a better prognosis than patients transplanted for malig- 
nant conditions.8
 
Figure 2: Driving time estimated using Google Maps (Google 
LLC., Mountain View, California, USA) of patients who 
received allogeneic haematopoietic stem cell transplant- 
ation with and without acute graft-versus-host disease from 
home to the transplant centre of Sultan Qaboos University 
Hospital, Muscat, Oman (N = 170).
 
Figure 3: Overall survival of patients who received haemato- 
poietic stem cell transplantation. The y-axis represents the 
Kaplan-Meier estimate of the overall survival probability 
according to the median driving time from home to the 
transplant centre at Sultan Qaboos University Hospital, 
Muscat, Oman (N = 170).
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Furthermore, data suggests that an increase in DTC 
is not associated with the development of aGvHD 
(P = 0.918). Al-Khabori et al.’s study showed that the 
incidence of aGvHD in patients transplanted at SQUH 
was 32% while the incidence of chronic GvHD was 
16%.8 Similar reasons as for the OS outcome could also 
be applicable for the aGvHD outcome. The development 
of aGvHD has been inconsistently shown to impact 
OS in international studies.3
There are a number of limitations in the present 
study. Since this was a retrospective study, there is a high 
chance of selection bias. Additionally, the small sample 
size most likely contributed to the low statistical power 
and therefore affects the ability to make definitive con- 
clusions. The use of Google Maps (Google LLC.) online 
application to estimate driving time and distance from 
home to SQUH is another limitation as the application 
produced different driving times at different times of 
the day. This is likely due to the fact that Google Maps 
(Google LLC.) incorporates the current traffic conditions 
to estimate the driving time. Therefore, early morning 
estimates on working days were used for all patients to 
improve consistency and accuracy. Finally, this study 
spanned a large time period. The driving conditions and 
the supportive therapy may have changed during this 
period. The results of this study should be interpreted 
in light of these limitations. However, this study is the 
first to report the lack of impact of home-to-transplant 
centre distance and driving time on the OS of patients 
undergoing allogeneic HSCT in Oman as well as the 
risk of developing aGvHD.
Conclusion
This study suggests that driving distance is not assoc- 
iated with the mortality or the development of aGvHD. 
Larger and prospective studies should be conducted to 
more accurately assess the impact of DTC in the future 
in Oman and the region.
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